What is NDC 23155-170?

23155-170 is the product NDC for Zoledronic acid, Zoledronic acid 4 mg/5mL injection, solution, concentrate, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zoledronic acid?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zoledronic acid NDC 23155-170 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-170Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0170Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-170-31	2315501703123155017031	1 VIAL, GLASS in 1 CARTON (23155-170-31) / 5 mL in 1 VIAL, GLASSMarketed from Aug 31, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zoledronic acid
Generic name (nonproprietary): zoledronic acid
Active ingredients: Zoledronic acid — 4 mg/5mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.NDC labeler code 23155
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201783
Marketing start: Aug 31, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Diphosphonates (Chemical structure)
Identifiers: Product ID 23155-170_f4991976-8a87-4a00-839f-3f62c561c230SPL ID f4991976-8a87-4a00-839f-3f62c561c230SPL set ID 00a5bd5a-e5ee-4bad-b510-a4d4485485c8RxCUI 351114UNII 6XC1PAD3KFUPC 0323155170313
Pharmacologic class: Bisphosphonate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N423155017031 followed by a unit qualifier and the quantity

Package 23155-0170-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 18, 2023.

Indications (excerpt from the label)

Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy. (1.1) Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy. (1.2) Limitations of Use : The safety and efficacy of zoledronic acid injection has not been established for use in hyperparathyroidism or non-tumor-related hypercalcemia. 1.1 Hypercalcemia of Malignancy Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy defined as an albumin-corrected calcium (cCa) of greater…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 23155-170

What is NDC 23155-170?: 23155-170 is the product NDC for Zoledronic acid, Zoledronic acid 4 mg/5mL injection, solution, concentrate, listed with the FDA by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zoledronic acid.
What is the active ingredient?: Zoledronic acid.
Who is the labeler?: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., NDC labeler code 23155. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zoledronic acid?: 32 other product NDCs are listed under this name. See all Zoledronic acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zoledronic acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
zoledronic acid	Zoledronic acid .04 mg/mL	Injection, SolutionIntravenous	Gland Pharma Limited	68083-672	68083-0672-01
Zoledronic Acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	BPI Labs LLC	54288-183	54288-0183-01
Zoledronic Acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	Avenacy Inc.	83634-801	83634-0801-05
Zoledronic acid	Zoledronic acid 5 mg/100mL	InjectionIntravenous	BluePoint Laboratories	68001-611	68001-0611-33
Zoledronic acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	BluePoint Laboratories	68001-610	68001-0610-25
Zoledronic Acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	Gland Pharma Limited	68083-615	68083-0615-01
Zoledronic acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	NORTHSTAR RX LLC	72603-198	72603-0198-01
Zoledronic Acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	Dr. Reddy's Laboratories Inc.	43598-233	43598-0233-11
Zoledronic acid	Zoledronic acid 5 mg/100mL	InjectionIntravenous	FOSUN PHARMA USA INC	72266-152	72266-0152-01
Zoledronic Acid	Zoledronic acid 5 mg/100mL	Injection, SolutionIntravenous	Meitheal Pharmaceuticals Inc.	71288-806	71288-0806-51

All 33 Zoledronic acid NDCs

Other NDCs under ANDA 201783

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201783
Product	Strength	Form · route	Labeler	Product NDC
Zoledronic acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	BluePoint Laboratories	68001-610
Zoledronic acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	NORTHSTAR RX LLC	72603-198
Zoledronic Acid	Zoledronic acid 4 mg/5mL	Injection, Solution, ConcentrateIntravenous	Avenacy Inc.	83634-801